Gilead Sciences, Inc. (GILD) earnings
GILD earnings moved a median of +0.61% by the close. Quarterly and annual GILD reports and results, each read against the price at its own news timestamp. Back to the GILD overview →
33 measured GILD earnings events.
Where these GILD earnings landedvs 33 measured GILD earnings reactions
| Middle 50% of GILD earnings reactions | -0.75% to +1.28% |
|---|---|
| Median reaction (to close) | +0.61% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 GILD earnings events with a measured close landed between -0.75% and +1.28%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Gilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences | Press release | +0.02% | +1.06% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Jun 30 | SEC filing · Form 10-Q | -0.64% | +0.84% | |
| Gilead Sciences Announces Second Quarter 2026 Financial Results | Press release | +0.41% | -3.12% | |
| Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 | Press release | -0.51% | -1.13% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Mar 31 | SEC filing · Form 10-Q | +1.24% | +1.02% | |
| Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences | Press release | +0.03% | +1.27% | |
| Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 | Press release | +0.10% | -0.28% | |
| Form 10-K GILEAD SCIENCES, INC. For: Dec 31 | SEC filing · Form 10-K | +0.90% | -0.16% | |
| Gilead Sciences Announces 3.8 Percent Increase in First Quarter 2026 Dividend | Press release | +1.71% | +4.91% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.18% | -0.71% | |
| Gilead Sciences Announces Third Quarter 2025 Financial Results | Press release | +2.58% | +3.21% | |
| Gilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025 | Press release | +0.50% | -0.40% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Jun 30 | SEC filing · Form 10-Q | +4.13% | +3.83% | |
| Gilead Sciences Announces Second Quarter 2025 Financial Results | Press release | +4.13% | +3.83% | |
| Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 | Press release | +1.38% | +1.57% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Mar 31 | SEC filing · Form 10-Q | -1.87% | +0.80% | |
| Gilead Sciences Announces First Quarter 2025 Financial Results | Press release | -0.59% | +0.36% | |
| Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025 | Press release | -0.81% | +1.42% | |
| Form 10-K GILEAD SCIENCES, INC. For: Dec 31 | SEC filing · Form 10-K | +0.27% | +0.86% | |
| Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend | Press release | +1.23% | +1.28% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.14% | -2.08% | |
| Gilead Sciences Announces Third Quarter 2024 Financial Results | Press release | +2.97% | +4.15% | |
| Gilead Sciences to Release Third Quarter 2024 Financial Results on Wednesday, November 6, 2024 | Press release | -0.13% | -1.35% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Jun 30 | SEC filing · Form 10-Q | +1.04% | -1.71% | |
| Gilead Sciences Announces Second Quarter 2024 Financial Results | Press release | +1.04% | -1.71% | |
| Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 | Press release | +0.92% | +1.29% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.49% | -0.92% | |
| Gilead Sciences Announces First Quarter 2024 Financial Results | Press release | +0.64% | -0.12% | |
| Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024 | Press release | +0.32% | +1.13% | |
| Form 10-K GILEAD SCIENCES, INC. For: Dec 31 | SEC filing · Form 10-K | +0.33% | -0.75% | |
| Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2024 Dividend | Press release | -1.39% | -2.35% | |
| Form 10-Q GILEAD SCIENCES, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.42% | +0.61% | |
| Gilead Sciences Announces Third Quarter 2023 Financial Results | Press release | -1.42% | +0.61% |
Keep exploring
More GILD: analyst actions → · SEC filings → · GILD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Marinus Pharmaceuticals, Inc. (MRNS) | 687 | 0.00% | 50% |
| PTC Therapeutics, Inc. (PTCT) | 686 | +0.01% | 50% |
| ONCOMED PHARMACEUTICALS (OMED) | 677 | -0.20% | 44% |
| ARATANA THERAPEUTICS (PETX) | 677 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.